Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
Blood
; 135(13): 1049-1057, 2020 03 26.
Article
in En
| MEDLINE
| ID: mdl-31932840
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Complement System Proteins
/
Hematopoietic Stem Cell Transplantation
/
Complement Inactivating Agents
/
Thrombotic Microangiopathies
/
Antibodies, Monoclonal, Humanized
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Journal:
Blood
Year:
2020
Type:
Article